Beware: The Misuse of Technology and the Law of Unintended Consequences

Neurotherapeutics

Volumn 4, Issue 3, 2007, Pages 549-554

  Freeman, John M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

aEEG; automated EEG; Ethics of study design; fetal heart rate monitoring

Indexed keywords

ARTICLE; ELECTROENCEPHALOGRAM; FETUS MONITORING; LAW; MEDICAL TECHNOLOGY; PRIORITY JOURNAL;

BRAIN DISEASES; CLINICAL TRIALS; ELECTROENCEPHALOGRAPHY; FEMALE; FETAL MONITORING; HUMANS; INFANT, NEWBORN; PREGNANCY; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 34250752273     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.04.003     Document Type: Article

References (23)

1. Hofmann B. The technological invention of disease. J Med Ethics 27 (2001) 10-19
2. Fisher E.S., and Welch H.G. Avoiding the unintended consequences of growth in medical care: how might more be worse?. JAMA 281 (1999) 446-453
3. Clancy R.R. Summary proceedings from the Neurology Group on Neonatal Seizures. Pediatrics 117 (2006) S23-S27
4. Graham E.M., Peterson S.M., Christo D.K., and Fox H.E. Intrapartum electronic fetal heart rate monitoring and the prevention of perinatal brain injury. Obstet Gynecol 108 (2006) 656-666
5. Royal College of Obstetricians and Gynaecologists. The use of electronic fetal monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance (2001), RCOG Press, London
6. Alfirevic Z., Devane D., and Gyte G.M. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev 3 (2006) CD006066
7. Nelson K. Can we prevent cerebral palsy?. N Engl J Med 349 18 (2003) 1765-1769
8. Greene M.F. Obstetricians still await a deus ex machina. N Engl J Med 355 (2006) 2247-2248
9. Freeman J.M. The use of amplitude-integrated electroencephalography: beware of its unintended consequences. Pediatrics 119 (2007) 615-617
10. Rosen I. the physiological basis for continuous electroencephalogram monitoring in the neonate. Clin Perinatol 33 (2006) 593-611 v
11. Greisen G. Brain monitoring in the neonate: the rationale. Clin Perinatol 33 (2006) 613-618 v-vi
12. Rogawski M.A. Point-counterpoint: do interictal spikes trigger seizures or protect against them?. Epilepsy Curr 6 (2006) 197-198
13. Staley K.J., and Dudek F.E. Interictal spikes and epileptogenesis. Epilepsy Curr 6 (2006) 199-202
14. Avoli M., Biagini G., and de Curtis M. Do interictal spikes sustain seizures and epileptogenesis?. Epilepsy Curr 6 (2006) 203-207
15. Murray D.M., Ryan C.A., Boylan G.B., et al. Prediction of seizures in asphyxiated neonates: correlation with continuous video-electroencephalographic monitoring. Pediatrics 118 (2006) 41-46
16. Freeman A.D., and Freeman J.M. No-fault cerebral palsy insurance: an alternative to the obstetrical malpractice lottery. J Health Polit Policy Law 14 (1989) 707-718
17. Shankaran S., and Laptook A. Challenge of conducting trials of neuroprotection in the asphyxiated term infant. Semin Perinatol 27 (2003) 320-332
18. Gunn A.J., Battin M., Gluckman P.D., Gunn T.R., and Bennet L. Therapeutic hypothermia: from lab to NICU. J Perinat Med 33 (2005) 340-346
19. Goodman S.N. Ethics and evidence in clinical trials. Clin Trials 2 (2005) 195-196
20. Hlatky M.A., Owens D.K., and Sanders G.D. Cost-effectiveness as an outcome in randomized clinical trials. Clin Trials 3 (2006) 543-551
21. Gray A.M. Cost-effectiveness analysis alongside randomized clinical trials. Clin Trials 3 (2006) 538-542
22. U.S. Food and Drug Administration. Innovation or stagnation?. Challenge and opportunity on the critical pathway to new medical products (2004), FDA. http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.pdf [Available at: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.pdf].
23. Botkin J.R., Clayton E.W., Fost N.C., et al. Newborn screening technology: proceed with caution. Pediatrics 117 (2006) 1793-1799